TC Medical(SH:600763) Sou Hu Cai Jing·2026-01-28 11:27Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Tongce Medical (600763), indicating a decline in stock price and mixed capital flow trends [1][2] - As of January 28, 2026, Tongce Medical's stock closed at 45.17 yuan, down 2.08%, with a turnover rate of 1.96% and a trading volume of 87,700 hands, resulting in a transaction amount of 398 million yuan [1] - In terms of capital flow on January 28, 2026, the net outflow of main funds was 41.39 million yuan, accounting for 10.39% of the total transaction amount, while retail investors saw a net inflow of 69.01 million yuan, representing 17.33% of the total transaction amount [1] Group 2 - For the first three quarters of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, a year-on-year increase of 2.56%, and a net profit attributable to shareholders of 514 million yuan, up 3.16% year-on-year [2] - The third quarter of 2025 showed a single-quarter main revenue of 842 million yuan, reflecting a year-on-year increase of 2.34%, with a net profit of 192 million yuan, also up 2.31% year-on-year [2] - The company has a debt ratio of 25.1%, investment income of 41.22 million yuan, financial expenses of 31.93 million yuan, and a gross profit margin of 41.69% [2] Group 3 - Over the past 90 days, five institutions have provided ratings for Tongce Medical, with three buy ratings and two hold ratings, and the average target price set by institutions is 52.15 yuan [2]